OncoSec Medical Announces YTD Results as of April 30, 2014

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced financial results for the nine months ended A



from Content Keyword RSS http://ift.tt/SFQFNX

via IFTTT